Michael Chen to Tissue Plasminogen Activator
This is a "connection" page, showing publications Michael Chen has written about Tissue Plasminogen Activator.
Connection Strength
0.174
-
Nogueira RG, Gupta R, Jovin TG, Levy EI, Liebeskind DS, Zaidat OO, Rai A, Hirsch JA, Hsu DP, Rymer MM, Tayal AH, Lin R, Natarajan SK, Nanda A, Tian M, Hao Q, Kalia JS, Chen M, Abou-Chebl A, Nguyen TN, Yoo AJ. Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients. J Neurointerv Surg. 2015 Jan; 7(1):16-21.
Score: 0.118
-
Mocco J, Fiorella D, Fargen KM, Albuquerque F, Chen M, Gupta R, Hirsch JA, Linfante I, Mack W, Rai AT, Tarr RW. Endovascular therapy for acute ischemic stroke is indicated and evidence based: a position statement. J Neurointerv Surg. 2015 Feb; 7(2):79-81.
Score: 0.031
-
Gupta R, Tayal AH, Levy EI, Cheng-Ching E, Rai A, Liebeskind DS, Yoo AJ, Hsu DP, Rymer MM, Zaidat OO, Lin R, Natarajan SK, Nogueira RG, Nanda A, Tian M, Hao Q, Abou-Chebl A, Kalia JS, Nguyen TN, Chen M, Jovin TG. Intra-arterial thrombolysis or stent placement during endovascular treatment for acute ischemic stroke leads to the highest recanalization rate: results of a multicenter retrospective study. Neurosurgery. 2011 Jun; 68(6):1618-22; discussion 1622-3.
Score: 0.025